Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis-Reference-Cited by-同舟云学术

Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis

Published:2009-10 Issue:5 Volume:14 Page:468-472
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Yamada Tadaaki,Ohtsubo Koushiro,Mouri Hisatsugu,Yamashita Kaname,Yasumoto Kazuo,Izumi Kouji,Zen Yoh,Watanabe Hiroyuki,Yano Seiji

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-008-0869-9.pdf

Reference23 articles.

1. Anker CJ, Dechet C, Isaac JC, et al. (2008) Small-cell carcinoma of the prostate. J Clin Oncol 26:1168–1171

2. Papandreou CN, Daliani DD, Thall PF, et al. (2002) Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20:3072–3080

3. Amato RJ, Logothetis CJ, Hallinan R, et al. (1992) Chemotherapy for small cell carcinoma of prostatic origin. J Urol 147:935–937

4. Taylor HG, Lefkowitz M, Skoog SJ, et al. (1984) Intracranial metastases in prostate cancer. Cancer 53:2728–2730

5. Glantz MJ, Cole BF, Glantz LK, et al. (1998) Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 82:733–739

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leptomeningeal metastases in prostate cancer: A review of the current literature;Current Urology;2024-09

2. Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer;Anticancer Research;2023-08-30

3. The Clinical, Diagnostic, Therapeutic, and Prognostic Characteristics of Brain Metastases in Prostate Cancer: A Systematic Review;Prostate Cancer;2022-11-27

4. Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment;Biomedicines;2021-04-12

5. Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective;Expert Review of Anticancer Therapy;2016-08-26